MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Senseonics sees activist investor take a major stake

Senseonics sees activist investor take a major stake

By

Senseonics LogoActivist investor Sessa Capital has taken a sizeable stake in long-term, implantable CGM company Senseonics (NYSE: SENS), according to an SEC Schedule 13G filed today.

The SEC filing lists Sessa directly owning 4,437,532 shares of Senseonics common stock, with warrants to buy another 8,000,000 shares of stock subject to a 9.9% blocker provision that prevents investors from owning 10% or more without being subject to SEC “insider” rules.

According to the hedge fund’s quarterly reports, Sessa owned 1,766,093 shares of Senseonics as of March 31.

Go to our sibling site Drug Delivery Business News for more background information.

More recent news

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].